Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques.

Annovazzi A, Bonanno E, Arca M, D'Alessandria C, Marcoccia A, Spagnoli LG, Violi F, Scopinaro F, De Toma G, Signore A.

Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):117-26. Epub 2005 Oct 12.

PMID:
16220305
2.

Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study.

Cortellaro M, Cofrancesco E, Arbustini E, Rossi F, Negri A, Tremoli E, Gabrielli L, Camera M.

Thromb Haemost. 2002 Jul;88(1):41-7.

PMID:
12152675
3.

Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging.

Adams GJ, Greene J, Vick GW 3rd, Harrist R, Kimball KT, Karmonik C, Ballantyne CM, Insull W Jr, Morrisett JD.

Magn Reson Imaging. 2004 Nov;22(9):1249-58.

PMID:
15607096
4.

Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques.

Durán MC, Martín-Ventura JL, Mohammed S, Barderas MG, Blanco-Colio LM, Mas S, Moral V, Ortega L, Tuñón J, Jensen ON, Vivanco F, Egido J.

Eur J Pharmacol. 2007 May 7;562(1-2):119-29. Epub 2007 Feb 8.

PMID:
17336287
5.
6.

Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.

Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Kihara T, Tanaka N, Nakaya K, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):222-8. doi: 10.1097/HJR.0b013e32832948a0.

PMID:
19242355
7.

Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.

Erbel C, Dengler TJ, Wangler S, Lasitschka F, Bea F, Wambsganss N, Hakimi M, Böckler D, Katus HA, Gleissner CA.

Basic Res Cardiol. 2011 Jan;106(1):125-34. doi: 10.1007/s00395-010-0135-y. Epub 2010 Dec 1.

PMID:
21116822
8.

Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy.

Fujimoto S, Hartung D, Ohshima S, Edwards DS, Zhou J, Yalamanchili P, Azure M, Fujimoto A, Isobe S, Matsumoto Y, Boersma H, Wong N, Yamazaki J, Narula N, Petrov A, Narula J.

J Am Coll Cardiol. 2008 Dec 2;52(23):1847-57. doi: 10.1016/j.jacc.2008.08.048.

10.

One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.

Avellone G, Di Garbo V, Abruzzese G, Campisi D, De Simone R, Raneli G, Licata G.

Int Angiol. 2006 Mar;25(1):26-34.

11.

In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.

Larmann J, Frenzel T, Schmitz M, Hahnenkamp A, Demmer P, Immenschuh S, Tietge UJ, Bremer C, Theilmeier G.

Anesthesiology. 2013 Jul;119(1):129-41. doi: 10.1097/ALN.0b013e318291c18b.

PMID:
23559030
12.

Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients.

Opalinska M, Stompor T, Pach D, Mikolajczak R, Fedak D, Krzanowski M, Rakowski T, Sowa-Staszczak A, Glowa B, Garnuszek P, Maurin M, Karczmarczyk U, Sulowicz W, Hubalewska-Dydejczyk A.

Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):673-82. doi: 10.1007/s00259-011-2026-3. Epub 2012 Jan 12.

13.

99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study.

Signore A, Annovazzi A, Barone R, Bonanno E, D'Alessandria C, Chianelli M, Mather SJ, Bottoni U, Panetta C, Innocenzi D, Scopinaro F, Calvieri S.

J Nucl Med. 2004 Oct;45(10):1647-52.

14.

Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.

Goicoechea M, de Vinuesa SG, Lahera V, Cachofeiro V, Gómez-Campderá F, Vega A, Abad S, Luño J.

J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S231-5.

15.

The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia.

Ozaki K, Kubo T, Imaki R, Shinagawa H, Fukaya H, Ohtaki K, Ozaki S, Izumi T, Aizawa Y.

J Atheroscler Thromb. 2006 Aug;13(4):216-9.

16.

Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.

Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, Chu B, Takaya N, Liu F, Polissar NL, Neradilek B, Raichlen JS, Cain VA, Waterton JC, Hamar W, Hatsukami TS.

Am Heart J. 2008 Mar;155(3):584.e1-8. doi: 10.1016/j.ahj.2007.11.018. Epub 2008 Jan 18. Erratum in: Am Heart J. 2008 Jun;155(6):1127.

PMID:
18294500
17.

Impaired expression of interleukin-2 receptor (IL2R) in the immunosuppressed burned patient: reversal by exogenous IL2.

Teodorczyk-Injeyan JA, Sparkes BG, Mills GB, Falk RE, Peters WJ.

J Trauma. 1987 Feb;27(2):180-7.

PMID:
3102753
18.

Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study.

Zhao XQ, Phan BA, Chu B, Bray F, Moore AB, Polissar NL, Dodge JT Jr, Lee CD, Hatsukami TS, Yuan C.

Am Heart J. 2007 Aug;154(2):239-46.

PMID:
17643572
19.

In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery.

Glaudemans AW, Bonanno E, Galli F, Zeebregts CJ, de Vries EF, Koole M, Luurtsema G, Boersma HH, Taurino M, Slart RH, Signore A.

Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1710-9. doi: 10.1007/s00259-014-2764-0. Epub 2014 Apr 16.

PMID:
24737117
20.

Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging.

Parolini C, Marchesi M, Lorenzon P, Castano M, Balconi E, Miragoli L, Chaabane L, Morisetti A, Lorusso V, Martin BJ, Bisgaier CL, Krause B, Newton RS, Sirtori CR, Chiesa G.

J Am Coll Cardiol. 2008 Mar 18;51(11):1098-103. doi: 10.1016/j.jacc.2007.12.010.

Supplemental Content

Support Center